Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
161.97
-1.97 (-1.20%)
Oct 14, 2025, 3:41 PM EDT - Market open
Insmed Revenue
Insmed had revenue of $107.42M in the quarter ending June 30, 2025, with 18.90% growth. This brings the company's revenue in the last twelve months to $398.11M, up 21.15% year-over-year. In the year 2024, Insmed had annual revenue of $363.71M with 19.17% growth.
Revenue (ttm)
$398.11M
Revenue Growth
+21.15%
P/S Ratio
74.46
Revenue / Employee
$313,222
Employees
1,271
Market Cap
34.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 363.71M | 58.50M | 19.17% |
| Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
| Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
| Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
| Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
INSM News
- 14 days ago - Insmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A Optionality - Seeking Alpha
- 22 days ago - Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 - PRNewsWire
- 4 weeks ago - Insmed Incorporated (INSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Insmed Incorporated (INSM) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 7 weeks ago - Insmed To Present at September Investor Conferences - PRNewsWire
- 7 weeks ago - Lung Disease-Focused Insmed 'Must-Own' Name For Investors - Benzinga
- 2 months ago - FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease - Benzinga